by Mark from Ottawa Canada Send more money for more research, right? Fact is that diabetes, be it of the type 1 or 2 variety, is making handsome profits for pharmaceutical share holders. It’s a condition that just keeps on giving – even to those who supposedly do “research” to find a “cure”. I have [...]